ResultsIQ

ResultsIQ › Latest results › Sanjivani Paranteral Ltd

Sanjivani Paranteral Ltd Q3 FY26 results press release summary

NSE: SANJIVIN · BSE: 531569

Results press release of 16 Feb 2026, summarised by AI from the filing.

Sanjivani Paranteral Q3 FY26 standalone revenue grew 20.25% YoY to ₹208.63 mn, with PAT up 37.8% YoY to ₹26.16 mn.

Key takeaways

  1. Q3 FY26 results Standalone revenue ₹208.63 mn, grew 20.25% YoY; PAT ₹26.16 mn, grew 37.8% YoY.
  2. Guidance Expanded manufacturing capabilities, widening geographic reach, and strengthening product pipeline are expected to drive steady growth.
  3. Pune facility SPL Infusion Pvt. Ltd., Pune contributed to consolidated revenues for the first time.
  4. Growth driver Oral segment revenue grew 153.5% YoY to ₹86.4 mn in Q3 FY26.
  5. Risk Forward-looking statements subject to risks like economic changes, tax laws, inflation and litigation.

Original filing on BSE

Sanjivani Paranteral Ltd earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.